Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jul 20;20(9):519. doi: 10.1038/s41577-020-0405-3

Antibody responses to SARS-CoV-2 short-lived

Nicolas Vabret 1,
PMCID: PMC7369565  PMID: 32686754

In the absence of confirmed cases of reinfection by SARS-CoV-2, the duration of immune protection elicited after initial infection is still unknown. This preprint describes a longitudinal analysis of antibody responses in 65 SARS-CoV-2-infected individuals. Although the magnitude of neutralizing antibody (nAb) responses correlated with disease severity, there was a rapid decline in nAb titres in most patients within 3 months after onset of symptoms. The authors argue that the transient nAb responses elicited by SARS-CoV-2 resemble those observed following seasonal coronavirus infections. However, the consequences on secondary immune responses and their ability to prevent reinfection remain to be determined.

Competing interests

The author declares no competing interests.

References

Original article

  1. Seow J, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv. 2020 doi: 10.1101/2020.07.09.20148429. [DOI] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES